Accepted for/Published in: JMIR Public Health and Surveillance
Date Submitted: Mar 13, 2024
Open Peer Review Period: Mar 13, 2024 - May 8, 2024
Date Accepted: Jul 6, 2024
(closed for review but you can still tweet)
AI Governance: A Problem for Public Health
ABSTRACT
Rapidly evolving artificial intelligence (AI) is capable of structuralizing social, political, and economic determinants of health into the invisible algorithms that shape every facet of modern life. Nevertheless, AI could be a powerful public health tool, enabling beneficial objectives like precision public health and medicine. Developing an AI governance framework that can maximize the benefits and minimize the risks of AI is a significant challenge. The benefits of public health engagement in AI governance could be extensive. Here, we describe how several public health concepts could enhance AI governance. Specifically, we explain how (1) harm reduction provides framework for navigating the governance debate between traditional regulation and “soft law” approaches; (2) a public health understanding of social determinants of health is essential to optimally weigh the potential risks and benefits of AI; (3) public health ethics provides a toolset for guiding governance decisions where individual interests intersect with collective interests; and (5) a One Health approach to AI governance can both improve governance effectiveness while advancing public health outcomes. Public health theories, perspectives, and innovations could substantially enrich and improve AI governance, creating a more equitable and socially beneficial path for AI development.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.